<SEC-DOCUMENT>9999999995-15-002173-index.html : 20150805
<SEC-HEADER>9999999995-15-002173.hdr.sgml : 20150805
<ACCEPTANCE-DATETIME>20150805001511
ACCESSION NUMBER:		9999999995-15-002173
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20150804
DATE AS OF CHANGE:		20150805
EFFECTIVENESS DATE:		20150804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NYMOX PHARMACEUTICAL CORP
		CENTRAL INDEX KEY:			0001018735
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-205659
		FILM NUMBER:		151027351

	BUSINESS ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
		BUSINESS PHONE:		1-800-936-9669

	MAIL ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>